475 related articles for article (PubMed ID: 29228933)
21. Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function.
van Horck M; Winkens B; Wesseling G; van Vliet D; van de Kant K; Vaassen S; de Winter-de Groot K; de Vreede I; Jöbsis Q; Dompeling E
Sci Rep; 2017 Sep; 7(1):12350. PubMed ID: 28955051
[TBL] [Abstract][Full Text] [Related]
22. Oral antibiotic prescribing patterns for treatment of pulmonary exacerbations in two large pediatric CF centers.
Hoppe JE; Hinds DM; Colborg A; Wagner BD; Morgan WJ; Rosenfeld M; Zemanick ET; Sanders DB
Pediatr Pulmonol; 2020 Dec; 55(12):3400-3406. PubMed ID: 32970375
[TBL] [Abstract][Full Text] [Related]
23. Bronchodilator responsiveness in cystic fibrosis children treated for pulmonary exacerbations.
Pollak M; Shaw M; Wilson D; Solomon M; Ratjen F; Grasemann H
Pediatr Pulmonol; 2021 Jul; 56(7):2036-2042. PubMed ID: 33830642
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.
Li Z; Lai HJ; Kosorok MR; Laxova A; Rock MJ; Splaingard ML; Farrell PM
Pediatr Pulmonol; 2004 Oct; 38(4):277-84. PubMed ID: 15334503
[TBL] [Abstract][Full Text] [Related]
25. Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?
Skolnik K; Nguyen A; Thornton CS; Waddell B; Williamson T; Rabin HR; Parkins MD
BMC Infect Dis; 2017 Oct; 17(1):660. PubMed ID: 28969684
[TBL] [Abstract][Full Text] [Related]
26. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.
Sanders DB; Solomon GM; Beckett VV; West NE; Daines CL; Heltshe SL; VanDevanter DR; Spahr JE; Gibson RL; Nick JA; Marshall BC; Flume PA; Goss CH;
J Cyst Fibros; 2017 Sep; 16(5):592-599. PubMed ID: 28460885
[TBL] [Abstract][Full Text] [Related]
27. Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study.
Somayaji R; Goss CH; Khan U; Neradilek M; Neuzil KM; Ortiz JR
Clin Infect Dis; 2017 Jun; 64(12):1760-1767. PubMed ID: 28329304
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis.
Sequeiros IM; Jarad N
Chron Respir Dis; 2012 Feb; 9(1):9-16. PubMed ID: 22308550
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of the modified Bhalla score for assessment of pulmonary exacerbations in adults with cystic fibrosis.
Diab-Cáceres L; Girón-Moreno RM; García-Castillo E; Pastor-Sanz MT; Olveira C; García-Clemente MM; Nieto-Royo R; Prados-Sánchez C; Caballero-Sánchez P; Olivera-Serrano MJ; Padilla-Galo A; Nava-Tomas E; Esteban-Peris A; Fernández-Velilla M; Torres M; Gómez-Punter RM; Ancochea J
Eur Radiol; 2021 Jan; 31(1):112-120. PubMed ID: 32740815
[TBL] [Abstract][Full Text] [Related]
30. Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation.
Kanga J; Kuhn R; Craigmyle L; Haverstock D; Church D
Clin Ther; 1999 Aug; 21(8):1343-56. PubMed ID: 10485506
[TBL] [Abstract][Full Text] [Related]
31. Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis.
Wagener JS; VanDevanter DR; Konstan MW; Pasta DJ; Millar SJ; Morgan WJ
Pediatr Pulmonol; 2020 Mar; 55(3):828-834. PubMed ID: 31746561
[TBL] [Abstract][Full Text] [Related]
32. Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis.
Rosenfeld M; Farrell PM; Kloster M; Swanson JO; Vu T; Brumback L; Acton JD; Castile RG; Colin AA; Conrad CK; Hart MA; Kerby GS; Hiatt PW; Mogayzel PJ; Johnson RC; Davis SD
Eur Respir J; 2013 Dec; 42(6):1545-52. PubMed ID: 23722613
[TBL] [Abstract][Full Text] [Related]
33. Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis.
Rayment JH; Stanojevic S; Davis SD; Retsch-Bogart G; Ratjen F
Thorax; 2018 May; 73(5):451-458. PubMed ID: 29449440
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis.
Sanders DB; Bittner RC; Rosenfeld M; Redding GJ; Goss CH
Pediatr Pulmonol; 2011 Apr; 46(4):393-400. PubMed ID: 20967845
[TBL] [Abstract][Full Text] [Related]
35. Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF.
Heltshe SL; West NE; VanDevanter DR; Sanders DB; Beckett VV; Flume PA; Goss CH;
Contemp Clin Trials; 2018 Jan; 64():35-40. PubMed ID: 29170074
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.
Regelmann WE; Schechter MS; Wagener JS; Morgan WJ; Pasta DJ; Elkin EP; Konstan MW;
Pediatr Pulmonol; 2013 Jul; 48(7):649-57. PubMed ID: 22949088
[TBL] [Abstract][Full Text] [Related]
37. Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection.
Bortoluzzi CF; Volpi S; D'Orazio C; Tiddens HA; Loeve M; Tridello G; Assael BM
J Cyst Fibros; 2014 Sep; 13(5):564-71. PubMed ID: 24726420
[TBL] [Abstract][Full Text] [Related]
38. Association of Inhaled Antibiotics in Addition to Standard Intravenous Therapy and Outcomes of Pediatric Inpatient Pulmonary Exacerbations.
Cogen JD; Faino AV; Onchiri F; Hoffman LR; Kronman MP; Nelson M; Nichols DP; Rosenfeld M; VanDevanter DR; Gibson RL
Ann Am Thorac Soc; 2020 Dec; 17(12):1590-1598. PubMed ID: 32726564
[No Abstract] [Full Text] [Related]
39. Clinical features associated with pulmonary exacerbation diagnosis in infants and young children with cystic fibrosis.
Corcoran A; Faig W; Ren CL
Pediatr Pulmonol; 2024 Apr; 59(4):874-879. PubMed ID: 38131505
[TBL] [Abstract][Full Text] [Related]
40. Routine ventilation scans in children with cystic fibrosis: diagnostic usefulness and prognostic value.
Jaffé A; Hamutcu R; Dhawan RT; Adler B; Rosenthal M; Bush A
Eur J Nucl Med; 2001 Sep; 28(9):1313-8. PubMed ID: 11585289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
